About Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: INO
- Previous Close: $6.60
- 50 Day Moving Average: $6.71
- 200 Day Moving Average: $7.79
- 52-Week Range: $5.85 - $11.69
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -6.06
- P/E Growth: 0.00
- Market Cap: $488.80M
- Outstanding Shares: 74,060,000
- Beta: 2.84
- Net Margins: -199.99%
- Return on Equity: -39.93%
- Return on Assets: -31.81%
Companies Related to Inovio Pharmaceuticals:
- Current Ratio: 3.39%
- Quick Ratio: 3.39%
What is Inovio Pharmaceuticals' stock symbol?
Inovio Pharmaceuticals trades on the NASDAQ under the ticker symbol "INO."
When did Inovio Pharmaceuticals' stock split? How did Inovio Pharmaceuticals' stock split work?
Shares of Inovio Pharmaceuticals reverse split on the morning of Friday, June 6th 2014. The 1-4 reverse split was announced on Friday, May 23rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 5th 2014. An investor that had 100 shares of Inovio Pharmaceuticals stock prior to the reverse split would have 25 shares after the split.
Where is Inovio Pharmaceuticals' stock going? Where will Inovio Pharmaceuticals' stock price be in 2017?
7 equities research analysts have issued 1-year target prices for Inovio Pharmaceuticals' shares. Their forecasts range from $11.00 to $18.00. On average, they expect Inovio Pharmaceuticals' share price to reach $14.00 in the next twelve months.
When will Inovio Pharmaceuticals announce their earnings?
Inovio Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.
Who owns Inovio Pharmaceuticals stock?
Inovio Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (3.44%), Allianz Asset Management AG (0.18%), Employees Retirement System of Texas (0.17%), ING Groep NV (0.12%), Russell Investments Group Ltd. (0.11%) and Metropolitan Life Insurance Co. NY (0.06%). Company insiders that own Inovio Pharmaceuticals stock include Angel Cabrera, Morton Collins, Niranjan Sardesai and Simon X Benito.
Who sold Inovio Pharmaceuticals stock? Who is selling Inovio Pharmaceuticals stock?
Inovio Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Dimensional Fund Advisors LP, AQR Capital Management LLC, Allianz Asset Management AG and Metropolitan Life Insurance Co. NY. Company insiders that have sold Inovio Pharmaceuticals stock in the last year include Niranjan Sardesai and Simon X Benito.
Who bought Inovio Pharmaceuticals stock? Who is buying Inovio Pharmaceuticals stock?
Inovio Pharmaceuticals' stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., ARK Investment Management LLC and Keybank National Association OH. Company insiders that have bought Inovio Pharmaceuticals stock in the last two years include Angel Cabrera, Morton Collins, Niranjan Sardesai and Simon X Benito.
How do I buy Inovio Pharmaceuticals stock?
Shares of Inovio Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Inovio Pharmaceuticals stock cost?
One share of Inovio Pharmaceuticals stock can currently be purchased for approximately $6.60.